These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15115957)

  • 21. Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis.
    Jover R; Rodrigo R; Felipo V; Insausti R; Sáez-Valero J; García-Ayllón MS; Suárez I; Candela A; Compañ A; Esteban A; Cauli O; Ausó E; Rodríguez E; Gutiérrez A; Girona E; Erceg S; Berbel P; Pérez-Mateo M
    Hepatology; 2006 Jun; 43(6):1257-66. PubMed ID: 16729306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
    Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
    Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amniotic membrane application reduces liver fibrosis in a bile duct ligation rat model.
    Sant'Anna LB; Cargnoni A; Ressel L; Vanosi G; Parolini O
    Cell Transplant; 2011; 20(3):441-53. PubMed ID: 20719087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of N-acetylcysteine on bile duct ligation-induced liver fibrosis in rats.
    Tahan G; Tarcin O; Tahan V; Eren F; Gedik N; Sahan E; Biberoglu N; Guzel S; Bozbas A; Tozun N; Yucel O
    Dig Dis Sci; 2007 Dec; 52(12):3348-54. PubMed ID: 17436097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemodynamic and renal evolution of the bile duct-ligated rat.
    Martínez-Prieto C; Ortíz MC; Fortepiani LA; Ruiz-Maciá J; Atucha NM; García-Estañ J
    Clin Sci (Lond); 2000 May; 98(5):611-7. PubMed ID: 10781394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anti-fibrotic effect of liver growth factor is associated with decreased intrahepatic levels of matrix metalloproteinases 2 and 9 and transforming growth factor beta 1 in bile duct-ligated rats.
    Díaz-Gil JJ; García-Monzón C; Rúa C; Martín-Sanz P; Cereceda RM; Miquilena-Colina ME; Machín C; Fernández-Martínez A; García-Cañero R
    Histol Histopathol; 2008 May; 23(5):583-91. PubMed ID: 18283643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of bone loss by bile duct ligation in rats.
    Mabuchi M; Kawamura I; Fushimi M; Inoue T; Takeshita S; Takakura S; Matsuo M; Tomoi M; Goto T
    In Vivo; 2001; 15(4):281-7. PubMed ID: 11695218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T1rho MR imaging is sensitive to evaluate liver fibrosis: an experimental study in a rat biliary duct ligation model.
    Wang YX; Yuan J; Chu ES; Go MY; Huang H; Ahuja AT; Sung JJ; Yu J
    Radiology; 2011 Jun; 259(3):712-9. PubMed ID: 21436087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifibrotic effect of Stephania tetrandra on experimental liver fibrosis induced by bile duct ligation and scission in rats.
    Nan JX; Park EJ; Lee SH; Park PH; Kim JY; Ko G; Sohn DH
    Arch Pharm Res; 2000 Oct; 23(5):501-6. PubMed ID: 11059831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Change in lipid profile and impairment of endothelium-dependent relaxation of blood vessels in rats after bile duct ligation.
    Ji H; Jiang JY; Xu Z; Kroeger EA; Lee SS; Liu H; Shen H; Zhang M; Minuk GY; Choy PC; Gong Y
    Life Sci; 2003 Jul; 73(10):1253-63. PubMed ID: 12850241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic and systemic effects of rosuvastatin on an experimental model of bile duct ligation in rats.
    Olteanu D; Nagy A; Dudea M; Filip A; Muresan A; Catoi C; Mircea PA; Clichici S
    J Physiol Pharmacol; 2012 Oct; 63(5):483-96. PubMed ID: 23211302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatoprotective and antifibrotic effects of sodium molybdate in a rat model of bile duct ligation.
    Ale-Ebrahim M; Eidi A; Mortazavi P; Tavangar SM; Tehrani DM
    J Trace Elem Med Biol; 2015 Jan; 29():242-8. PubMed ID: 25084733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms responsible for the altered pharmacokinetics of bosentan: analysis utilizing rats with bile duct ligation-induced liver dysfunction.
    Horiuchi I; Mori YI; Taguchi M; Ichida F; Miyawaki T; Hashimoto Y
    Biopharm Drug Dispos; 2009 Sep; 30(6):326-33. PubMed ID: 19639656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Perindopril and losartan attenuate intrahepatic Toll-like receptor 4 protein expression in rats with bile duct ligation-induced hepatic fibrosis].
    Ni S; Li Y; Huang S; Luo W; Li C; Li X
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):211-4. PubMed ID: 22381760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of hepatic cirrhosis on the pharmacokinetics of theophylline in rats.
    Nam BH; Sohn DH; Ko G; Kim JB
    Arch Pharm Res; 1997 Aug; 20(4):318-23. PubMed ID: 18975172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enantiomeric disposition of ketorolac in goats following administration of a single intravenous and oral dose.
    Nagilla R; Deshmukh DD; Copedge KJ; Miller S; Martin B; Bell EC; Duran SH; Ravis WR
    J Vet Pharmacol Ther; 2009 Feb; 32(1):49-55. PubMed ID: 19161455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and safety of ketorolac following single intranasal and intramuscular administration in healthy volunteers.
    McAleer SD; Majid O; Venables E; Polack T; Sheikh MS
    J Clin Pharmacol; 2007 Jan; 47(1):13-8. PubMed ID: 17192497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and evaluation of ketorolac transdermal systems.
    Choi JS; Cho YA; Chun IK; Jung SY; Gwak HS
    Drug Deliv; 2007 Feb; 14(2):69-74. PubMed ID: 17364870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and analgesic effect of ketorolac floating delivery system.
    Radwan MA; Abou El Ela Ael S; Hassan MA; El-Maraghy DA
    Drug Deliv; 2015 May; 22(3):320-7. PubMed ID: 24512312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous prediction of human pharmacokinetic parameters for ketorolac, a non-steroidal anti-inflammatory agent, using allometry approach.
    Gilibili RR; Mullangi R; Srinivas NR
    Eur J Drug Metab Pharmacokinet; 2011 Jun; 36(2):87-93. PubMed ID: 21380569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.